| Price | 560 to 590 |
|---|---|
| GMP Rumors | ₹0 |
| Lot size | 25 |
| Issue size | ₹8000 Cr |
| Allotment | 03-08-2026 |
| Listing | 05-08-2026 |
| Suggestion | May Apply |
| Allotment Status | Kfintech |
| Video | https://youtu.be/be_ByNzKcj4 |
BSE List Price : ₹
NSE List Price : ₹
| Category | Times |
|---|---|
| QIBs | 8.54x |
| HNIs | 1.06x |
| Retail | 0.97x |
| Total : 5.12x | |
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 25 | ₹14,750 |
| Retail Maximum | 13 | 325 | ₹191,750 |
| S-HNI Minimum | 14 | 350 | ₹206,500 |
| S-HNI Maximum | 67 | 1,675 | ₹988,250 |
| B-HNI Minimum | 68 | 1,700 | ₹1,003,000 |
Manipal Health Enterprises Limited is a leading healthcare provider in India with a broad network of hospitals, clinics, and diagnostic centres. The company is a part of the Manipal Group, established by T. M. A. Pai.
The company offers a wide range of healthcare services across various specialties, including organ transplantation, oncology, cardiology, neurology, orthopaedics, and preventive care.
Manipal Health is committed to providing quality healthcare services while enhancing access to medical care. As of September 30, 2025, it operated 38 hospitals (or 48 hospitals on a pro forma basis) with 10,761 operational beds (or 12,367 licensed beds on a pro forma basis). In addition, the company operated 17 clinics.
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹4927.57 | ₹4225.20 | ₹414.20 | ₹7936.78 |
| 2024 | ₹6265.17 | ₹5340.51 | ₹533.20 | ₹10818.83 |
| 2025 | ₹8362.79 | ₹7134.43 | ₹1081.67 | ₹14072.08 |
| 2026 | ₹10520.52 | ₹9268.42 | ₹916.52 | ₹24864.50 |
Dr. Ranjan Ramdas Pai
Manipal Global Health Services
Memg International Ltd.
Kangto Investments Pte. Ltd.
Imperius Healthcare Investments Pte. Ltd
Kabru Investments Pte. Ltd.
Experienced Management with Strong Shareholder Backing: The company is guided by a seasoned management team, supported by reputed institutional shareholders, providing leadership stability, operational strength, and a foundation for long-term growth.
Strong Presence Across Major Metro Cities: The company is the only private hospital chain with a dominant presence in Bengaluru, Kolkata, and Pune, complemented by a well-diversified network spanning both metro and non-metro locations.
Reliance on Inpatient Services: A substantial portion of the company's revenue is generated from inpatient admissions and hospital occupancy. Any decline in patient admissions or occupancy levels could adversely affect its revenue and profitability.
Operational & Regulatory Compliance Risk: The company is exposed to risks such as legal proceedings, regulatory actions, operational disruptions, medical equipment failures, and hospital interruptions, which may negatively impact its financial performance and reputation.
Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the Material Subsidiaries, Manipal Hospitals Private Limited
Acquisition of minority stake in the stepdown Subsidiary, Sahyadri Hospitals Private Limited
General corporate purposes
Manipal Health Enterprises Ltd.
The Annexe,
98/2, Rustom Bagh,
HAL Airport Road,
Bengaluru, Karnataka, 560017
Phone: +9180 4936 0300
Email: legalcs@manipalhospitals.com
Website: https://www.manipalhospitals.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: manipal.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
May Apply